Interestingly, as SHH-mediated signaling is essential for oligodendrocyte development in both gray and white matter, recent evidence suggests that SHH could prevent demyelination in several animal models of demyelinating diseases [13] and thus promote remyelination both in the peripheral and central nervous system. Here, SHH is linked to demyelinating disease.